申请人:Jolidon Synese
公开号:US20060167023A1
公开(公告)日:2006-07-27
The present invention relates to compounds of general formula IA or IB
wherein
X
1
and X
2
are each independently N or C—R″ and
R
1
, R
2
,R
3
, R
4
,
R
5
, and R
6
are as defined in the specification and to pharmaceutically acceptable acid addition salts thereof. The compounds can be used for the treatment of diseases related to the glycine transporter inhibitor, such as schizophrenia and Alzheimer's disease.
本发明涉及一般式IA或IB的化合物,其中X1和X2分别独立地为N或C—R″,R1、R2、R3、R4、R5和R6如规范中所定义,并且其药学上可接受的酸盐。这些化合物可用于治疗与甘氨酸转运体抑制剂相关的疾病,如精神分裂症和阿尔茨海默病。